{"product_id":"9780857114587-bnf-85","title":"BNF 85 (British National Formulary) March 2023","description":"\u003cmeta content=\"text\/html; charset=utf-8\" http-equiv=\"Content-Type\"\u003e\u003cp\u003e\u003cspan\u003e\u003cp\u003eThe British National Formulary (BNF) is the first choice for concise medicines information. Trusted by health professionals across the world to support confident decision-making at the point of care.\u003c\/p\u003e\n\u003cp\u003eThe new edition (BNF 85) provides up-to-date guidance on prescribing, dispensing, and administering medicines, plus legal and professional guidelines.\u003c\/p\u003e\n\u003cp\u003eExtensive content updates in the BNF 85 edition include:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNew monographs for:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAklief® (trifarotene) for acne vulgaris\u003c\/li\u003e\n\u003cli\u003eDrovelis® (drospirenone with estetrol)for hormonal contraception\u003c\/li\u003e\n\u003cli\u003eDucressa® (dexamethasone with levofloxacin)for prophylaxis or treatment of postoperative inflammation, or prevention of infection, following cataract surgery\u003c\/li\u003e\n\u003cli\u003eKerendia® (finerenone) for chronic kidney disease associated with type 2 diabetes\u003c\/li\u003e\n\u003cli\u003eMagnesium citrate for treatment and prevention of magnesium deficiency\u003c\/li\u003e\n\u003cli\u003eNetildex® (dexamethasone with netilmicin) for local treatment of eye inflammation and bacterial infection\u003c\/li\u003e\n\u003cli\u003eNettacin® (netilmicin) for local treatment of eye infection\u003c\/li\u003e\n\u003cli\u003eSibnayal® (potassium citrate with potassium bicarbonate) for distal renal tubular acidosis\u003c\/li\u003e\n\u003cli\u003eTenkasi® (oritavancin) for acute bacterial skin and skin structure infections\u003c\/li\u003e\n\u003cli\u003eVydura® (rimegepant) for treatment or prophylaxis of migraine\u003c\/li\u003e\n\u003cli\u003eXerava® (eravacycline) for complicated intra-abdominal infections\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMHRA advice on:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAnagrelide: risk of thrombosis, including cerebral infarction, if treatment discontinued abruptly\u003c\/li\u003e\n\u003cli\u003eDenosumab (Prolia®): should not be used in patients under 18 years due to the risk of serious hypercalcaemia\u003c\/li\u003e\n\u003cli\u003eDexmedetomidine: clinical trial finds increased risk of mortality in intensive care unit patients aged 65 years or younger\u003c\/li\u003e\n\u003cli\u003eMetformin hydrochloride: reduced vitamin B12 levels and new advice for monitoring patients at risk\u003c\/li\u003e\n\u003cli\u003eMethylphenidate hydrochloride long-acting (modified-release) preparations: caution if switching between products due to differences in formulations\u003c\/li\u003e\n\u003cli\u003eNebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and managed only by specialists\u003c\/li\u003e\n\u003cli\u003eRucaparib (Rubraca®): withdrawal of third-line treatment indication\u003c\/li\u003e\n\u003cli\u003eTopiramate (Topamax®): start of safety review triggered by a study reporting an increased risk of neurodevelopmental disabilities in children with prenatal exposure\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOther significant changes include updated guidance on:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAntibacterials for the prevention of secondary cases of diphtheria, and addition of guidance for the prevention of intra-uterine infection in preterm prelabour rupture of membranes\u003c\/li\u003e\n\u003cli\u003eContraceptive interactions\u003c\/li\u003e\n\u003cli\u003ePrescribing of drugs associated with dependence and withdrawal\u003c\/li\u003e\n\u003cli\u003eCOVID-19 vaccines\u003c\/li\u003e\n\u003cli\u003eManagement of depression\u003c\/li\u003e\n\u003cli\u003eDiphtheria vaccine\u003c\/li\u003e\n\u003cli\u003eManagement of epilepsy\u003c\/li\u003e\n\u003cli\u003eManagement of gout\u003c\/li\u003e\n\u003cli\u003ePost-exposure prophylaxis of herpesvirus infections\u003c\/li\u003e\n\u003cli\u003eHydrocortisone: addition of children’s dosing for adrenal crisis\u003c\/li\u003e\n\u003cli\u003eManagement of hypertension in patients with type 1 diabetes\u003c\/li\u003e\n\u003cli\u003eManagement of multiple sclerosis\u003c\/li\u003e\n\u003cli\u003eObstetrics: preterm labour\u003c\/li\u003e\n\u003cli\u003eTacrolimus: updated pregnancy, breast-feeding and monitoring advice\u003c\/li\u003e\n\u003cli\u003eType 1 diabetes: inclusion of continuous glucose monitoring in aims of treatment\u003c\/li\u003e\n\u003cli\u003eType 2 diabetes: use of non-insulin antidiabetic drugs\u003c\/li\u003e\n\u003cli\u003eValaciclovir: update to indication and doses in line with UK Health Security Agency recommendations on post-exposure prophylaxis for chickenpox and shingles\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOrder your copy and get:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eUp-to-date information on prescribing, dispensing, and administering medicines\u003c\/li\u003e\n\u003cli\u003eAuthoritative, independent guidance on best practice enabling you to select safe and effective medicines\u003c\/li\u003e\n\u003cli\u003eInformation you can trust for quality and reliability\u003c\/li\u003e\n\u003cli\u003eEverything you need at your fingertips, all in one book\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"Rarewaves","offers":[{"title":"Default Title","offer_id":40772482760801,"sku":"9780857114587","price":99.12,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0092\/7504\/8033\/files\/12b4efe82213047d342c75c0700116f9.png?v=1695832924","url":"https:\/\/www.rarewaves.com\/products\/9780857114587-bnf-85","provider":"Rarewaves.com","version":"1.0","type":"link"}